Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419575Aexternal-prioritypatent/GB8419575D0/en
Priority claimed from GB08519418Aexternal-prioritypatent/GB2162522B/en
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Publication of MY102564ApublicationCriticalpatent/MY102564A/en
A COMPOUND OF FORMULA (1)@@@(FORMULA 1)@@@AN ITS PHYSIOLOGICALLY ACCEPTABLE SALTS AND SOLVATES ARE DESCRIBED AS USEFUL IN TREATING AND/OR PREVENTING PAIN RESULTING FROM DILATATION OF THE CRANIAL OF THE CRANIAL VASCULATURE IN PARTICULAR MIGRAINE. THE COMPOUND (I) MAY BE PREPARED, FOR EXAMPLE BY CYCLISING A COMPOUND OF FORMULA (II)@@@(FORMULA 2)
Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds